Gastón Moré, Carlos Javier Panei, N. Fuentealba, C. Aspitia, M. E. Bravi, Javier Origlia, Magdalena Rambeaud, M. Tizzano, Gabriela Rudd Garcés, C. Golijow, J. M. Unzaga, Marcelo Pecoraro
{"title":"兽医科学学院新冠病毒19诊断单元第一次双月工作结果","authors":"Gastón Moré, Carlos Javier Panei, N. Fuentealba, C. Aspitia, M. E. Bravi, Javier Origlia, Magdalena Rambeaud, M. Tizzano, Gabriela Rudd Garcés, C. Golijow, J. M. Unzaga, Marcelo Pecoraro","doi":"10.24215/15142590e050","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic required rapid development and approval of diagnostic methods and kits. Nasal swab samples (n=1114) were derived to Faculty of Veterinary Sciences- UNLP COVID-19 diagnostic unit by the Buenos Aires Province Ministry of Health during June and July 2020, to perform molecular diagnosis of SARS- CoV-2. Samples of RNA were purified in a type II biosafety cabin and analyzed by real time RT-PCR with the GeneFinder™ kit, which amplifies 3 viral target genes (N, E y RdRp). Of the 1110 samples with positive internal control, 458 (41.2%) were positive (26.9% to all target genes, 4.2% to 2 target genes and almost 10% to one gene, mainly N). Percentage of positive samples remained similar throughout the study period, although the sample number was higher in July (781 samples; 315 positive) compared to June (333 samples; 143 positive). Samples from Berisso, Ensenada and La Plata had significantly lower positive rate than those coming from other counties (27.6% versus 60.7%, respectively). Positivity rate was higher in samples from patients with ≥3 clinical signs (55.6%). It is necessary to conduct inter-laboratory validation studies and standardization of diagnostic methods used in order to obtain reliable and reproducible results.","PeriodicalId":7773,"journal":{"name":"Analecta Veterinaria","volume":"40 1","pages":"050-050"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Resultados del primer bimestre de trabajo de la unidad de diagnóstico COVID-19 de la Facultad de Ciencias Veterinarias-UNLP\",\"authors\":\"Gastón Moré, Carlos Javier Panei, N. Fuentealba, C. Aspitia, M. E. Bravi, Javier Origlia, Magdalena Rambeaud, M. Tizzano, Gabriela Rudd Garcés, C. Golijow, J. M. Unzaga, Marcelo Pecoraro\",\"doi\":\"10.24215/15142590e050\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The COVID-19 pandemic required rapid development and approval of diagnostic methods and kits. Nasal swab samples (n=1114) were derived to Faculty of Veterinary Sciences- UNLP COVID-19 diagnostic unit by the Buenos Aires Province Ministry of Health during June and July 2020, to perform molecular diagnosis of SARS- CoV-2. Samples of RNA were purified in a type II biosafety cabin and analyzed by real time RT-PCR with the GeneFinder™ kit, which amplifies 3 viral target genes (N, E y RdRp). Of the 1110 samples with positive internal control, 458 (41.2%) were positive (26.9% to all target genes, 4.2% to 2 target genes and almost 10% to one gene, mainly N). Percentage of positive samples remained similar throughout the study period, although the sample number was higher in July (781 samples; 315 positive) compared to June (333 samples; 143 positive). Samples from Berisso, Ensenada and La Plata had significantly lower positive rate than those coming from other counties (27.6% versus 60.7%, respectively). Positivity rate was higher in samples from patients with ≥3 clinical signs (55.6%). It is necessary to conduct inter-laboratory validation studies and standardization of diagnostic methods used in order to obtain reliable and reproducible results.\",\"PeriodicalId\":7773,\"journal\":{\"name\":\"Analecta Veterinaria\",\"volume\":\"40 1\",\"pages\":\"050-050\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-10-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Analecta Veterinaria\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24215/15142590e050\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analecta Veterinaria","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24215/15142590e050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Resultados del primer bimestre de trabajo de la unidad de diagnóstico COVID-19 de la Facultad de Ciencias Veterinarias-UNLP
The COVID-19 pandemic required rapid development and approval of diagnostic methods and kits. Nasal swab samples (n=1114) were derived to Faculty of Veterinary Sciences- UNLP COVID-19 diagnostic unit by the Buenos Aires Province Ministry of Health during June and July 2020, to perform molecular diagnosis of SARS- CoV-2. Samples of RNA were purified in a type II biosafety cabin and analyzed by real time RT-PCR with the GeneFinder™ kit, which amplifies 3 viral target genes (N, E y RdRp). Of the 1110 samples with positive internal control, 458 (41.2%) were positive (26.9% to all target genes, 4.2% to 2 target genes and almost 10% to one gene, mainly N). Percentage of positive samples remained similar throughout the study period, although the sample number was higher in July (781 samples; 315 positive) compared to June (333 samples; 143 positive). Samples from Berisso, Ensenada and La Plata had significantly lower positive rate than those coming from other counties (27.6% versus 60.7%, respectively). Positivity rate was higher in samples from patients with ≥3 clinical signs (55.6%). It is necessary to conduct inter-laboratory validation studies and standardization of diagnostic methods used in order to obtain reliable and reproducible results.